1. Market Research
  2. > Healthcare
  3. > Pathology Market Trends
Global Conjunctivitis Market: Trend Analysis and Forecast to 2022

Global Conjunctivitis Market: Trend Analysis and Forecast to 2022

  • August 2016
  • 100 pages
  • ID: 4652947
  • Format: PDF

Summary

Table of Contents

The global conjunctivitis market is projected to grow with a CAGR between 2.1% and 2.5% during 2016-2022 and reach USD X.XX billion by 2022. Conjunctivitis or pink eye is an inflammation or redness of the lining of the white part of the eye and the underside of the eyelid that can be caused by infection, allergic reaction, or physical agents like infrared or ultraviolet light. Conjunctivitis is an extremely common eye problem because the conjunctiva is continually exposed to microorganisms and environmental agents that can cause infections or allergic reactions. It can also affect one or both eyes and, if caused by infection, can be very easily transmitted to others during close physical contact, particularly among children in a daycare center. Thus, people diagnosed with conjunctivitis are recommended not to travel public places for that period of time.

Increasing awareness among patient population about pink eye disease, entry of new drugs and unmet need for viral conjunctivitis are considered to be the key factors driving the growth of this market. Unfavorable government regulations, expiring drug patents of major blockbusters and the growing demand for antibacterial drugs has impacted the demand for branded drugs are the key restraining factors for the growth of this market. Since, there are no approved drugs for the treatment of viral conjunctivitis, many companies are developing drugs which are expected to aid in the treatment of viral conjunctivitis and their effect will turn into a prominent opportunity to promote growth of this market over the forecast period. Moreover, loss of patent exclusivities and increasing demand for generic antibacterial drugs over branded drugs are the major challenges faced by this market.

Segments Covered:
The report segments the conjunctivitis market by disease type and by region. Market segmentation based on disease type includes Bacterial conjunctivitis, viral conjunctivitis and Allergic conjunctivitis. Furthermore, Allergic conjunctivitis segment is anticipated to grow at the highest CAGR over the forecast period accounted for more than 45% of the total market share by 2022. The key factor driving the growth of allergic conjunctivitis segment, are considered to be the different allergies present in the environment such as cold, acute respiratory infection, or other diseases such as measles, herpes simplex , or herpes zoster.

Geographic Coverage and Analysis:
The report provides regional analysis covering geographies such as North America, Europe, Asia Pacific, Latin America and Rest of the World (RoW). North America along with Latin America accounted for the largest market share together occupying more than 50% share of global market and is expected to continue its dominance over the forecast period. Increasing awareness among the patient and availability of multiple treatment options are expected to drive the growth in this region. Moreover, Asia Pacific is anticipated to grow at the highest CAGR over the forecast period and provides the opportunity for market growth due to presence of major players and increasing R&D activities.

Companies profiled:
The companies covered in the report include
- Akorn
- Alcon
- Allergan, Inc.
- Bausch & Lomb
- Celsus Therapeutics
- Eleven Biotherapeutics
- Griffin Discoveries
- InSiteVision
- Merck
- Nicox
- NovaBay
- Ocular Therapeutix
- Santen Pharmaceutical
- Starpharma
- Sun Pharma
- Pfizer, Inc.

Report Highlights:
The report provides deep insights on demand forecasts, market trends and micro and macro indicators. In addition, this report provides insights on the factors that are driving and restraining the demand of conjunctivitis globally as well as regionally. Moreover, IGR-Growth Matrix analysis given in the report brings an insight on the investment areas that existing or new market players can consider. The report provides insights into the market using analytical tools such as Porter’s five forces analysis and value chain analysis of conjunctivitis market. Moreover, the study highlights current market trends and provides forecast from 2016 to 2022. We also have highlighted future trends in the conjunctivitis market that will impact the demand during the forecast period. Moreover, the competitive analysis given in each regional market brings an insight on the market share of the leading players. Additionally, the analysis highlights rise and fall in the market shares of the key players in the market.

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 150+ Million searchable statistics with tables, figures & datasets
  • More than 25,000 trusted sources
  • Single User License — provides access to the report by one individual.
  • Department License — allows you to share the report with up to 5 users
  • Site License — allows the report to be shared amongst all employees in a defined country
  • Corporate License — allows for complete access, globally.
Ahmad helps you find the right report:
Testimonials

The research specialist advised us on the best content for our needs and provided a great report and follow-up, thanks very much we shall look at ReportLinker in the future.

Kate Merrick

Global Marketing Manager at
Eurotherm by Schneider Electric

We were impressed with the support that ReportLinker’s research specialists’ team provided. The report we purchased was useful and provided exactly what we want.

Category Manager at
Ikea

ReportLinker gave access to reliable and useful data while avoiding dispersing resources and spending too much time on unnecessary research.

Executive Director at
PwC Advisory

The customer service was fast, responsive, and 100% professional in all my dealings (...) If we have more research needs, I'll certainly prioritize working with ReportLinker!

Scott Griffith

Vice President Marketing at
Maurice Sporting Goods

The research specialist provided prompt, helpful instructions for accessing ReportLinker's product. He also followed up to make sure everything went smoothly and to ensure an easy transition to the next stage of my research

Jessica P Huffman

Research Associate at
American Transportation Research Institute

Excellent customer service. Very responsive and fast.

Director, Corporate Strategy at
Ingredion

I reached out to ReportLinker for a detailed market study on the Air Treatment industry. The quality of the report, the research specialist’s willingness to solve my queries exceeded my expectations. I would definitely recommend ReportLinker for in-depth industry information.

Mariana Mendoza

Global Platform Senior Manager at
Whirlpool Corporation

Thanks! I like what you've provided and will certainly come back if I need to do further research works.

Bee Hin Png

CEO at
LDR Pte Ltd

The research specialist advised us on the best content for our needs and provided a great report and follow-up, thanks very much we shall look at ReportLinker in the future.

Kate Merrick

Global Marketing Manager at
Eurotherm by Schneider Electric

FAQ
  • How we can help
    • I am not sure if the report I am interested in will fulfill my needs. Can you help me?
    • Yes, of course. You can call us at +33(0) 4 37 65 17 03 or drop us an email at researchadvisor@reportlinker.com to let us know more about your requirements.
    • We buy reports often - can ReportLinker get me any benefits?
    • Yes. Set up a call with a Senior Research Advisor to learn more - researchadvisor@reportlinker.com or +33(0) 4 37 65 17 03.
    • I have had negative experiences with market research reports before. How can you avoid this from happening again?
    • We advise all clients to read the TOC and Summary and list your questions so that we can get more insight for you before you make any purchase decision. A research advisor will accompany you so that you can compare samples and reports from different sources, and choose the study that is right for you.

  • Report Delivery
    • How and when I will receive my Report?
    • Most reports are delivered right away in a pdf format, while others are accessed via a secure link and access codes. Do note that sometimes reports are sent within a 12 hour period, depending on the time zones. However, you can contact us to escalate this. Should you need a hard copy, you can check if this option is offered for the particular report, and pay the related fees.
  • Payment conditions
    • What payment methods do you accept?
      1. Credit card : VISA, American Express, Mastercard, or
      2. You can download an invoice to pay by wire transfer, check, or via a Purchase Order from your company, or
      3. You can pay via a Check made out in US Dollars, Euros, or British Pounds for the full amount made payable to ReportLinker
    • What are ReportLinker’s Payment Terms?
    • All payments must normally be submitted within 30 days. However, you can let us know if you need extended time.
    • Are Taxes and duties included?
    • All companies based in France must pay a 20% tax per report. The same applies to all individuals based in the EU. All EU companies must supply their VAT number when purchasing to avoid this charge.
    • I’m not satisfied. Can I be refunded?
    • No. Once your order has been processed and the publisher has received a notification to send you the report, we cannot issue any refund or cancel any order. As these are not ‘traditional’ products that can be returned, reports that are dispatched are considered to be ‘consumed’.
  • User license
    • The license that you should acquire depends on the number of persons that need to access the report. This can range from Single User (only one person will have the right to read or access the report), or Department License (up to 5 persons), to Site License (a group of persons based in the same company location), or Corporate License (the entire company personnel based worldwide). However, as publishers have different terms and conditions, we can look into this for you.
Purchase Reports From Reputable Market Research Publishers
2019 Conjunctivitis Ongoing Clinical Trials Study- Companies, Countries, Drugs, Phases, Enrollment, Current Status and Markets

2019 Conjunctivitis Ongoing Clinical Trials Study- Companies, Countries, Drugs, Phases, Enrollment, Current Status and Markets

  • $ 2199
  • February 2019

The ongoing clinical trial research report- “2019 Conjunctivitis Ongoing Clinical Trials Study” analyzes the current scenario of all active Conjunctivitis trials across the world. The report presents ...

2019 Allergic Rhino-Conjunctivitis Ongoing Clinical Trials Study- Companies, Countries, Drugs, Phases, Enrollment, Current Status and Markets

2019 Allergic Rhino-Conjunctivitis Ongoing Clinical Trials Study- Companies, Countries, Drugs, Phases, Enrollment, Current Status and Markets

  • $ 2199
  • February 2019

The ongoing clinical trial research report- “2019 Allergic Rhino-Conjunctivitis Ongoing Clinical Trials Study” analyzes the current scenario of all active Allergic Rhino-Conjunctivitis trials across ...

2019 Rhino-Conjunctivitis Ongoing Clinical Trials Study- Companies, Countries, Drugs, Phases, Enrollment, Current Status and Markets

2019 Rhino-Conjunctivitis Ongoing Clinical Trials Study- Companies, Countries, Drugs, Phases, Enrollment, Current Status and Markets

  • $ 2199
  • February 2019

The ongoing clinical trial research report- “2019 Rhino-Conjunctivitis Ongoing Clinical Trials Study” analyzes the current scenario of all active Rhino-Conjunctivitis trials across the world. The report ...


ref:plp2016

Reportlinker.com © Copyright 2019. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.

Make sure you don’t miss any news and follow us on